{"id":727,"date":"2007-07-17T00:00:00","date_gmt":"2007-07-26T15:25:30","guid":{"rendered":""},"modified":"2022-09-25T21:32:41","modified_gmt":"2022-09-26T01:32:41","slug":"letter-to-department-of-foreign-affairs-and-international-trade-re-intellectual-property-issues-in-bilateral-fta-negotiations","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/letter-to-department-of-foreign-affairs-and-international-trade-re-intellectual-property-issues-in-bilateral-fta-negotiations\/","title":{"rendered":"Letter to Department of Foreign Affairs and International Trade re: Intellectual property issues in bilateral FTA negotiations"},"content":{"rendered":"&#8221;As one of the civil society organizations that has been actively engaged over several years in policy discussions with the federal government regarding the issue of intellectual property law and access to affordable medicines in developing countries \u2014 and in particular the provisions of Canada\u2019s Access to Medicines Regime (CAMR) \u2014 we write to raise our concern at the recent announcement by the Department of Foreign Affairs and International Trade (DFAIT) that it is assessing &#8216;the extent of Canadian intellectual property interests&#8217; in Peru, Colombia and the Dominican Republic, in the context of initiating trade agreement negotiations with these countries.&#8221;<br \/>\n<!-- Canada's Access to Medicines Regime, CAMR, Department of Foreign Affairs and International Trade, DFAIT, intellectual property, Free Trade Area of the Americas, FTAA, World Trade Organization, WTO, Agreement on Trade-Related Aspects of Intellectual Property, TRIPS, World Intellectual Property Organization, WIPO, Charter of the United Nations and the International Covenant on Economic, Social and Cultural Rights, Vienna Declaration on Human Rights --><p class=\"download-link-button\"><a class=\"download-link en\" title=\"Letter to Department of Foreign Affairs and International Trade re: Intellectual property issues in bilateral FTA negotiations\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/11197\/?tmstv=1777454584\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[145],"publication_type":[170],"publication_language":[184],"class_list":["post-727","publication22","type-publication22","status-publish","hentry","publication_topics-access-to-medicines","publication_type-advocacy","publication_language-english"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":3,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/727\/revisions"}],"predecessor-version":[{"id":20999,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/727\/revisions\/20999"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=727"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=727"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=727"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}